BCIS ACI 2020: This House Believes That, in Most Circumstances, DCB Therapy Is Equivalent to Implantation of DES

Published: 18 March 2020

  • Views:

    Views Icon 417
  • Likes:

    Heart Icon 7
  • episode_image
    9m 22s
    Part 4 Panel Discussion
    Julian P Gunn, Rodney H Stables, Simon Eccleshall
Average (ratings)
No ratings
Your rating

Overview

In this video series, chair of the debate, Prof Julian P Gunn (University of Sheffield, Sheffield, UK) introduces the panel and asks the audience of ACI 2020 to cast their votes on the motion “This house believes that, in most circumstances, DCB therapy is equivalent to implantation of DES”. Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK) argues that drug coated balloons (DCB) is equivalent or even better than drug eluting stents (DES) referring on recent data from BASKET-SMALL 2, Debut study. Whilst Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) argues against the motion that DCB therapy is equivalent to implantation of DES. The series concludes by furthering the arguments delivered by Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) and Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK).

This content was provided by the courtesy of BCIS.

More from this programme

Part 1

Introduction and Preliminary Poll

Chair of the debate, Prof Julian P Gunn (University of Sheffield, Sheffield, UK) introduces the panel and asks the audience of ACI 2020 to cast their votes on the motion “This house believes that, in most circumstances, DCB therapy is equivalent to implantation of DES”. This recording is provided by the courtesy of BCIS.Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK) argues that drug coated balloons (DCB) is equivalent or even better than drug eluting stents (DES) referring on recent data from BASKET-SMALL 2, Debut study.

Part 2

Pro Argument

Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK) argues that drug coated balloons (DCB) is equivalent or even better than drug eluting stents (DES) referring on recent data from BASKET-SMALL 2, Debut study.

Part 3

Contra Argument

Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) argues against the motion that DCB therapy is equivalent to implantation of DES. He dismisses the pro argument, arguing that the implantation of DES should remain the default approach.

Part 4

Panel Discussion

The panel and the chairs are concluding the debate by furthering the arguments delivered by Prof Rod Stables (Liverpool Heart and Chest Hospital, Liverpool, UK) and Dr Simon Eccleshall (Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK).

Faculty Biographies

Julian P Gunn

Julian P Gunn

Professor Julian P Gunn is a Honorary Consultant Cardiologist at the Sheffield Teaching Hospitals NHS Foundation Trust and Lead for Acute Coronary Syndrome Pathways, Sheffield Teaching Hospitals Foundation Trust.

View full profile
Simon Eccleshall

Simon Eccleshall

Consultant Cardiologist

Dr Simon Eccleshall is a consultant cardiologist at Spire Norwich Hospital. Dr Eccleshall's cardiology practice and research are focused on the major health issue of coronary artery disease. 

View full profile
Rodney H Stables

Rodney H Stables

Prof Stables is consultant cardiologist at LHCH — a specialist cardiothoracic unit and, in terms of procedure volume, one of the largest cardiac units in Europe. Prof Stables was the Chair of the Academic and Research Committee at the British Cardiovascular Society.

View full profile